Long-term outcomes after atrioventricular valve operations in patients undergoing single-ventricle palliation

Daniel J Wong1, Ajay J Iyengar, Gavin R Wheaton

  • 1Department of Cardiac Surgery, Royal Children's Hospital, and Department of Pediatrics, University of Melbourne, Melbourne, Australia.

Insights

Atrioventricular (AV) valve regurgitation in single ventricle patients poses significant risks, with high early mortality and long-term complications. Outcomes highlight the need for careful management and further research in this vulnerable population.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Surgery
  • Adult Congenital Heart Disease

Background:

  • Outcomes following atrioventricular (AV) valve operations in patients with functional single ventricles are not well-established.
  • AV valve regurgitation presents a significant challenge in single ventricle physiology, particularly in young patients.

Purpose of the Study:

  • To evaluate the outcomes of atrioventricular (AV) valve operations in patients with functional single ventricles.
  • To identify predictors of mortality and morbidity after AV valve surgery in this population.

Main Methods:

  • A retrospective review of 76 consecutive patients with single ventricles who underwent AV valve operations for regurgitation between 1988 and 2010.
  • Procedures included valve replacements, repairs, and closures. Kaplan-Meier survival and freedom from reoperation/thromboembolic events were analyzed.

Main Results:

  • Hospital mortality was 17%, with 1- and 10-year survival rates of 72% and 61%, respectively.
  • Independent predictors of mortality included common AV valve, need for mechanical circulatory support, and timing of operation relative to bidirectional cavopulmonary shunt (BCPS).
  • Long-term morbidity included moderate to severe regurgitation in 23% of survivors, pacemaker implantation in 6 patients, and decreased Fontan completion rates.

Conclusions:

  • AV valve regurgitation is a substantial burden in single ventricle patients, associated with significant early mortality and long-term morbidity.
  • The study identified key risk factors for adverse outcomes, emphasizing the complexity of managing these patients.
  • Survival and functional outcomes, including Fontan completion, are impacted by AV valve operations in single ventricle physiology.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...